Jones Financial Companies
DWTX

Jones Financial Companies’s Dogwood Therapeutics DWTX Stock Holding History

Jones Financial Companies’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264 Buy
+160
New +$265 ﹤0.01% 4832

Other funds holding DWTX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jones Financial Companies's DWTX Position: Q2 2026 in Review

Jones Financial Companies opened a new position in Dogwood Therapeutics (DWTX) in Q2 2026: 160 shares worth $264. The stake represents ﹤0.01% of the portfolio and ranks #4832 among its holdings.

15 funds tracked by Wall St. Rank hold DWTX as of Q2 2026.

  • Jones Financial Companies held 160 shares of Dogwood Therapeutics worth $264 as of Q2 2026.
  • Dogwood Therapeutics was a new Jones Financial Companies position in Q2 2026.
  • Dogwood Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4832 holding.
  • 15 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.